MS and MG patients have increased numbers of Th1 and Th17 cells along with their associated cytokines IL-1, IL-6, IL-17, IFN-γ, and tumor necrosis factor (TNF)-α (Table 1) [21–26]. Here, TNF is linked to myeloid sarcoma.